Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.34 (
lipoprotein lipase
)
7,025
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The metabolism of very-low-density lipoproteins and chylomicrons includes the extrahepatic hydrolysis of their triglycerides by
lipoprotein lipase
. This results in cholesterol-rich "remnants" which are further metabolised by the liver. There is experimental evidence that in both patients with type-III hyperlipoproteinaemia and cigarette smokers hepatic-remnant metabolism may be depressed. In type-III hyperlipoproteinaemia the defect is inherited while in smokers it occurs in response to raised blood concentrations of carboxyhaemoglobin. The striking clinical similarity between type-III hyperlipoproteinaemic patients and smokers--namely, a high incidence of peripheral vascular disease--may be due to a common cause, the accumulation of cholesterol-rich remnants in the plasma.
...
PMID:Peripheral vascular disease in cigarette smokers and impaired hepatic metabolism of lipoprotein remnants. 7 34
Immunochemical methods including fused rocket-, crossed-, and tandem-crossed immunoelectrophoresis, have been used to characterize the elution pattern from heparin-Sepharose affinity, chromatography of human post-heparin plasma. Hepatic triglyceride lipase (H-TGL) but not
lipoprotein lipase
(
LPL
) could be visualized with beta-naphthyl acetate after immunoelectrophoresis. Two proteins were found to elute together with the lipolytic enzymes. The amino acid composition of fractions containing these proteins was nearly identical to that of antithrombin III. These results indicate that the removal of antithrombin III is the major problem in the purification of H-TGL and
LPL
from human post-heparin plasma by heparin-Sepharose affinity chromatography.
...
PMID:Heparin-sepharose affinity chromatography of human post-heparin plasma. Characterization of the elution pattern with immunoelectrophoretic methods. 7 64
The effect of two synthetic heparinoids, SP-54 and Depot-Thrombocid, on serum lipids was studied in 17 patients with primary hyperlipidaemia (types IIb, IV and V of Fredrickson) and 15 healthy persons. SP-54 had no lipid-lowering effect, neither on oral nor rectal suppository application. Intramuscular injection of Depot-Thrombocid, however, resulted in a decrease of serum triglyceride concentrations of maximally 50% after six hours. There was a marked increase in the activity of the two lipolytic enzymes,
lipoprotein lipase
and hepatic triglyceride lipase in plasma, as well as an increase in free fatty acids and an extension of thrombin time and PTT. Twenty-four hours after injection all values returned to pretreatment levels. Intramuscular administration of Depot-Thrombocid two or three times a week for seven weeks had no lasting effect on serum lipids. However, there were considerable side effects such as haemorrhagic diatheses, hair loss and thrombocytopenia.
...
PMID:[Mechanism of action of synthetic heparinoids: results in patients with hypertriglyceridaemia (author's transl)]. 7 86
Most of the many metabolic abnormalities associated with obesity are corrected by weight reduction. Adipose-tissue lipoprotein-lipase activity per cell is increased in obesity. Adipose-tissue lipoprotein-lipase was significantly higher in seven previously obese men studied at a stable reduced weight than in a control population. In fact, enzyme activity was significantly higher than would have been predicted from the obese men's maximum weight. These results indicate that abnormalities in adipose-tissue
lipoprotein lipase
may have a primary role in the development of obesity.
...
PMID:Increased adipose-tissue lipoprotein-lipase activity in moderately obese men after weight reduction. 7 95
The effects of the administration of different fatty liver inducing drugs on the serum
lipoprotein lipase
activating ability was investigated in rats. Addition of serum from 2-mercaptoethanol-, 2-mercaptoacetate-, ethionine- or D-galactosamine- treated rats failed to activate heart and adipose tissue
lipoprotein lipase
from control rats. The activating effect of serum was only slightly reduced in isopropanol-treated rats, whereas it was found unaffected in ethanol-treated ones. Electrophoresis of the lipoproteins and of the very low density lipoproteins (VLDL) fraction of sera from 2-mercaptoethanol-, 2-mercaptoacetate-, isopropanol-, ethionine- and D-galactosamine-treated rats suggest that the lack of
lipoprotein lipase
activation ability of these sera is most probably related to the impairing effects of these drugs upon VLDL metabolism, i.e. reduction of VLDL secretion in the case of 2-mercaptoethanol, 2-mercaptoacetate and isopropanol, production of abnormal VLDL in the case of D-galactosamine and both decreased VLDL secretion and production of abnormal VLDL in the case of ethionine.
...
PMID:Loss of the lipoprotein lipase activating ability of rat serum after administration of some fatty liver inducing drugs. 8 Sep 91
Two men aged 48 and 35 years with severe hypertriglyceridaemia, glucose intolerance, and a secondary anaemia had more apolipoprotein C-III-2 and less apo C-III-1 on their triglyceride-rich lipoproteins (d less than 1.006) than did types IV or V lipaemic controls. Although the patients' abnormal lipoproteins seemed to produce normal activation of
lipoprotein lipase
, they did not serve as an efficient substrate for purified
lipoprotein lipase
. Adipose tissue of case 1 had considerable lipoprotein-lipase activity and the hypertriglyceridaemia responded to dietary therapy (carbohydrate 180 g, fat 80 g, protein 60 g per day, and no alcohol). The haemolytic anaemia improved, but the patient remained glucose intolerant. The abnormal content of apo C-III-2 on the triglyceride-rich lipoproteins, rendering them resistant to clearance by
lipoprotein lipase
, is believed to have contributed to the patients' severe hypertriglyceridaemia.
...
PMID:Hypertriglyceridaemia associated with an abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-III-2. 9 Jul 60
Lipoprotein lipase was purified from bovine milk and labeled with 125I. After intravenous injection to rats the labeled lipase rapidly disappeared from the blood. The initial half-life was about 1 min and more than 70% of the radioactivity was found in the liver at 10 min. 30 min after the injection about 10% of the injected radioactivity was present in acid-soluble form in blood, indicating that the enzyme had been rapidly degraded. Injection of asialofetuin, ribonuclease B or mannan in amounts known to block the hepatic receptors for glycoproteins with exposed galactose, N-acetylglucosamine or mannose residues did not retard the removal of the
lipoprotein lipase
. Thus, some other, as yet undefined, receptor is implicated. Lipoprotein lipase is known to bind to heparin and some related polysacchrides. Heparin injected before the enzyme delayed its removal and heparin injected after the enzyme caused an immediate increase in blood radioactivity, signifying return from tissues to blood of labeled enzyme. Lipoprotein lipase is present at the endothelium in several extrahepatic tissues and is rapidly turned over. Its presence in blood in appreciable amounts would cause a derangement of lipid transport. The efficient hepatic removal of the enzyme may thus serve an important physiological purpose in keeping the blood levels of this enzyme low.
...
PMID:Rapid removal to the liver of intravenously injected lipoprotein lipase. 9 43
The ketogenic potential of Intralipid was studied in two groups of infants: 12 were SGA and 15 AGA; all were clinically stable and less than 48 hours of age. During four-hour Intralipid tolerance tests, the SGA infants achieved significantly higher plasma TG and FFA levels. Both groups of infants significantly increased the concentration of ketone bodies; however, there was no difference in the levels achieved. In view of the slower clearance rate of TG and the higher levels of FFA in SGA infants, it is speculated that in addition to a possible defective
lipoprotein lipase
system and a decrease in number and size of the adipose cells, beta-oxidation of FFA to ketones may be occurring at a slower rate. The generation of high levels of ketones during Intralipid infusion period in both groups of infants indicates that SGA infants can handle ketone bodies as readily as AGA infants.
...
PMID:Lipid metabolism in the neonate. III. The ketogenic effect of Intralipid infusion in the neonate. 9 42
Postheparin serum lipolytic activities (hepatic and extrahepatic), serum free fatty acid, and triglyceride levels were measured in 16 kwashiorkor, 14 marasmic, and 14 control children. The results showed that the reduction in total postheparin lipolytic activity in kwashiorkor was in the activity of hepatic origin. In marasmus, the total postheparin lipolytic activity, hepatic and extrahepatic activities, were within normal range. The was no evidence for the presence of inhibitors of postheparin lipolytic activity in the serum of kwashiorkor or marasmic children. Fasting serum-free fatty acid level was significantly elevated in kwashiorkor, while the level in marasmus was not significantly different from control value. The serum triglyceride levels in both conditions showed no significant differences from the control value. These findings suggest that the defective production of hepatic
lipoprotein lipase
, as well as increased influx of free fatty acid into the liver, could account for the accumulation of fat in the liver of kwashiorkor and not in that of marasmic children.
...
PMID:Studies on hepatic and extrahepatic lipoprotein lipases in protein-calorie malnutrition. 10 20
Lipoprotein lipase and salt-resistant lipase were isolated from human post-heparin plasma. The proteins of human post-plasma
lipoprotein lipase
and salt-resistant lipase were identified and demonstrated to be immunologically different. Significant differences between the two enzymes in their relative amino acid composition were demonstrated, which indicates that the two enzymes are different proteins. When analysed by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, the enzymes seemed to have monomer molecular weights similar to that of
lipoprotein lipase
purified from bovine milk.
...
PMID:Properties of salt-resistant lipase and lipoprotein lipase purified from human post-heparin plasma. 11 2
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>